Skip to Main Content

Medications: Are They Safe and Effective?

Medications: Are They Safe and Effective?

Dr. Tuckson speaks with Angela Sandlin, PharmD, pharmacy director at Baptist Health LaGrange, about medication safety, availability and effectiveness.
S17 E1 Length 26:33 Premiere: 10.3.21

Providing Information and Dispelling Myths About Vaccines and Medications During the COVID-19 Pandemic

On the season premiere of Kentucky Health, host Dr. Wayne Tuckson welcomed Angela Sandlin, PharmD, the pharmacy director at Baptist Health LaGrange, to discuss the safety, availability, and effectiveness of vaccines and medications used for the SARS COVID-2 virus.

Explaining Our Thorough and Safe National Drug Development System

Ever since the SARS COVID-2 virus spread throughout the U.S. in spring 2020, information about medications that could potentially be used to treat the novel coronavirus has been front and center in national news. The media coverage only increased during late fall 2020 and into this year as the first vaccines developed to prevent serious complications from the virus were distributed.

As a result, many people for the first time began paying close attention to how medications and vaccines are developed, tested, and approved, which is a complex process. Dr. Sandlin says the public interest is welcome and that drug approval is something all citizens should learn about.

“The development of a vaccine or any medication goes through a number of steps,” Sandlin says. “The first being an investigational new drug application. That’s the pre-clinical testing, if you will, where [scientists] are testing compounds to see if they have utility. And if they find one that’s hopeful, then they can go into Phase 1 testing.”

Phase 1 testing, Sandlin explains, recruits a small number of healthy volunteers (20 to 80), and they are given the medication and tested for safety. If all goes well, the process moves to Phase 2, involving 100 to 300 patients who have the disease the drug was created to treat. In this phase, the medication is tested for efficacy as well as for any side effects. Control group testing is involved in this phase.

Phase 3 testing involves several thousand patients that have the illness, Sandlin says. This is a diverse group in terms of age and racial background, and the patients also may have different co-morbidities and/or are afflicted with other diseases aside from the one the drug is treating.

“If, and only if, it passes through all of those phases, then it gets a new drug application with the Food and Drug Administration (FDA),” Sandlin says. After detailed review of all research on the drug in question by FDA staff, a decision is made by an advisory group to recommend or deny the drug’s approval. “The FDA usually accepts that recommendation, but that advisory group is made up of physicians, pharmacologists, all sorts of clinicians, scientists, looking at all of this complex data to make sure the medication is safe,” Sandlin says.

Any medications that are approved by the FDA will undergo what Sandlin terms a “post-marketing study.” This compiles data on the drug after it is distributed to thousands of people to keep tabs on any new side effects that may become apparent and to find out if the drug may actually be beneficial in treating other ailments.

According to Sandlin, Phase 2 testing typically lasts two years and Phase 3 lasts three years. It can take an average of 12 years for a medication to move from initial application to the market, and she says that only 1 in 12 medications even make it to the investigational phase.

This term “off label” has been publicized in relation to the SARS COVID-2 virus, and Sandlin explains that it refers to the process whereby medications are used to treat conditions they weren’t initially developed to treat. She acknowledges that prescribing a medication “off label” has led to breakthroughs in medical treatment on occasion. “Technically, physicians can of course go off label – that is something that can be done at the physician’s prerogative,” she says. “But I think prescribers look for evidence, and they do look for other studies being done. …We always go by evidence-based care.”

Two medications that have been in the news over the past year – Hydroxychloroquine, a drug used to treat malaria patients, and Ivermectin, an anti-parasitic drug – have been discussed as effective off-label treatment methods for patients with the coronavirus. Sandlin says that Ivermectin was shown to have some activity against the coronavirus, but only in lab research. “However, so far in the studies, the dose needed to treat (the virus) in someone’s body – which is way different from in a test tube – is very high,” she says. “So there are some different clinical studies going on, but at the same time, using it off label is not recommended.

“One thing we don’t want to do with off-label medications is delay treatment by using an unknown medication when we have known treatments that can work,” Sandlin continues. “And we’ve seen that happen, unfortunately.”

How Vaccines and Medications Can Curb the Pandemic

As the coronavirus swept through the U.S. during spring 2020, the Donald Trump Administration started Operation Warp Speed, a ramped-up, coordinated campaign enlisting the government and pharmaceutical companies to develop, test, and authorize use of vaccines that would fight COVID-19, the disease arising from infection by the coronavirus. The first vaccines for COVID-19 were given in late 2020, meaning the endeavor lived up to its name, and then some.

However, the fast track process to develop and administer the Pfizer, Moderna, and Johnson & Johnson COVID vaccines also generated a high degree of suspicion among millions of vaccine-hesitant citizens who have concerns about their safety. Sandlin says such concerns are understandable, but are not warranted in this case.

“I don’t think we cut corners, I think we cut red tape,” she says. “I think the evidence will show you that it was a collaboration between some wonderful health organizations, the government, and our private industry in developing something and not cutting corners, with all hands on deck.”

Furthermore, Sandlin explains that the underlying structure of both the Pfizer and Moderna vaccines – which is called mRNA technology and modifies part of the coronavirus’ spike protein to induce an immune response within the body – has been researched extensively for several years prior to the pandemic. “We just didn’t have the perfect opportunity, if you will, to try it out – and we were ready,” she says.

Another issue causing concern among some Americans involves the initial authorization of all three COVID vaccines. They were granted emergency use authorization by the government rather than the FDA approval that is normally the final verdict on a drug’s safety. “An emergency use authorization is just what it sounds like – we have a severe pandemic, a problem that is a threat to life and the health of our country and our world, and it warrants us pulling out stops, doing the studies putting this ahead of other things,” Sandlin says. “Emergency use authorization doesn’t mean corners were cut. …I just say that this virus, and these vaccines, were a huge priority because everybody in science knew what a threat it was.”

Sandlin says that the ultimate test of the COVID vaccines’ safety and effectiveness has been proven by the fact that around 200 million Americans have taken them with very rare instances where negative side effects were found.

In addition to the vaccines, as of fall 2021 two medications have become commonly used to treat patients who have COVID-19: Regeneron and Remdesivir. Sandlin explains that Remdesivir is an anti-viral medication that is given intravenously to patients with the coronavirus who have been hospitalized. Regeneron, on the other hand, is a monoclonal antibody drug that is given intravenously to patients soon after they start showing symptoms of COVID-19 with the goal of keeping them from becoming gravely ill and being hospitalized. Sandlin says that Regeneron is primarily given to persons who have high co-morbidities for developing severe illness if they become infected, such as diabetes, high blood pressure, and cancer. Regeneron is most effective if given around four days after a patient is first diagnosed with COVID-19 symptoms, Sandlin adds.

Both Regeneron and Remdesivir are being administered under an emergency use authorization, and Sandlin observes that many persons with COVID-19 who have refused to get vaccinated are more than willing to receive these medications that are also not fully FDA-approved for treatment. “You’re trading one for the other,” she says, “but I’ll tell you, you’re much better off to prevent anything than to wait until you actually have the illness.”

Sandlin says that demand for Regeneron is spiking in Kentucky and other states as more studies show its effectiveness in preventing severe disease from the coronavirus. This has led state officials and medical leaders to explore ways to improve access to Regeneron by distributing the drug to areas where it is most needed and by opening regional infusion centers. “The other thing that has been a challenge for us is having the staff to administer the medication,” she says. “A lot of work is being done on that as we beat this virus back.”

Sandlin has some take-home messages for viewers who have developed a newfound and intense interest in the medication approval process since this global pandemic began. “I can tell you unequivocally that the United States has the safest system for the development of medications in the world – I have all the confidence in that. I have enough experience as a pharmacist to bear that out,” she says. “The medications we use to treat COVID-19 are improving, and the vaccine is the answer to keeping from ever getting COVID in the first place. An ounce of prevention is worth a pound of cure, and that little shot has done a lot of good.”

Program Details

Kentucky Health

About Kentucky Health

Learn how to improve your health through education and increased awareness. Dr. Wayne Tuckson, a colorectal surgeon in Louisville, hosts.

TV Schedules

Jump to Recent Airdates

Upcoming

Medications: A Modern Miracle, But Are They Safe and Available

Dr. Tuckson speaks with Angela Sandlin, PharmD, pharmacy director at Baptist Health LaGrange, about medication safety, availability and effectiveness.

  • Friday December 3, 2021 1:30 pm ET on KETKY
  • Friday December 3, 2021 12:30 pm CT on KETKY
  • Friday December 3, 2021 6:00 pm ET on KET
  • Friday December 3, 2021 5:00 pm CT on KET
  • Sunday December 5, 2021 12:30 am ET on KETKY
  • Saturday December 4, 2021 11:30 pm CT on KETKY
  • Sunday December 5, 2021 9:00 am ET on KETKY
  • Sunday December 5, 2021 8:00 am CT on KETKY

Lung Cancer: Improving Treatment and Decreasing the Mortality

Though lung cancer remains the leading cause of death from cancer in the United States, there is cause for optimism. Dr. Tuckson talks to Jason Chesney, M.D., director of the UofL Health-Brown Cancer Center in Louisville, about new developments in the treatment of lung cancer.

  • Sunday December 5, 2021 5:30 pm ET on KETKY
  • Sunday December 5, 2021 4:30 pm CT on KETKY
  • Monday December 6, 2021 2:00 pm ET on KET2
  • Monday December 6, 2021 1:00 pm CT on KET2
  • Friday December 10, 2021 1:30 pm ET on KETKY
  • Friday December 10, 2021 12:30 pm CT on KETKY
  • Friday December 10, 2021 6:00 pm ET on KET
  • Friday December 10, 2021 5:00 pm CT on KET
  • Friday December 10, 2021 11:30 pm ET on KET
  • Friday December 10, 2021 10:30 pm CT on KET
  • Sunday December 12, 2021 12:30 am ET on KETKY
  • Saturday December 11, 2021 11:30 pm CT on KETKY
  • Sunday December 12, 2021 7:00 am ET on KET2
  • Sunday December 12, 2021 6:00 am CT on KET2
  • Sunday December 12, 2021 9:00 am ET on KETKY
  • Sunday December 12, 2021 8:00 am CT on KETKY

Lung Health: Breathing Does a Body Good

Dr. Neal Moser, a pulmonologist and president of the Kentucky Medical Association, discusses the most common threats to our lungs and the best ways to protect them.

  • Sunday December 12, 2021 12:30 pm ET on KET
  • Sunday December 12, 2021 11:30 am CT on KET
  • Sunday December 12, 2021 5:30 pm ET on KETKY
  • Sunday December 12, 2021 4:30 pm CT on KETKY
  • Monday December 13, 2021 2:00 pm ET on KET2
  • Monday December 13, 2021 1:00 pm CT on KET2
  • Friday December 17, 2021 1:30 pm ET on KETKY
  • Friday December 17, 2021 12:30 pm CT on KETKY
  • Friday December 17, 2021 6:00 pm ET on KET
  • Friday December 17, 2021 5:00 pm CT on KET
  • Friday December 17, 2021 11:30 pm ET on KET
  • Friday December 17, 2021 10:30 pm CT on KET
  • Sunday December 19, 2021 12:30 am ET on KETKY
  • Saturday December 18, 2021 11:30 pm CT on KETKY
  • Sunday December 19, 2021 7:00 am ET on KET2
  • Sunday December 19, 2021 6:00 am CT on KET2
  • Sunday December 19, 2021 9:00 am ET on KETKY
  • Sunday December 19, 2021 8:00 am CT on KETKY

Otitis Media: Impact on Hearing and Learning

Dr. Swapna Kartha Chandran, an otolaryngologist with UofL Health, talks about the impact of recurrent otitis media (ear infection) on learning and hearing in young children.

  • Sunday December 19, 2021 12:30 pm ET on KET
  • Sunday December 19, 2021 11:30 am CT on KET
  • Sunday December 19, 2021 5:30 pm ET on KETKY
  • Sunday December 19, 2021 4:30 pm CT on KETKY
  • Monday December 20, 2021 2:00 pm ET on KET2
  • Monday December 20, 2021 1:00 pm CT on KET2
  • Friday December 24, 2021 1:30 pm ET on KETKY
  • Friday December 24, 2021 12:30 pm CT on KETKY
  • Friday December 24, 2021 6:00 pm ET on KET
  • Friday December 24, 2021 5:00 pm CT on KET
  • Friday December 24, 2021 11:30 pm ET on KET
  • Friday December 24, 2021 10:30 pm CT on KET
  • Sunday December 26, 2021 12:30 am ET on KETKY
  • Saturday December 25, 2021 11:30 pm CT on KETKY
  • Sunday December 26, 2021 7:00 am ET on KET2
  • Sunday December 26, 2021 6:00 am CT on KET2
  • Sunday December 26, 2021 9:00 am ET on KETKY
  • Sunday December 26, 2021 8:00 am CT on KETKY

GERD: A Burning in the Chest and a Whole Lot More

Gastroesophageal Reflux Disease, also known as GERD, is a painful but common condition caused by irritation in the lining of the esophagus. Dr. Tuckson talks with Jeff Allen, M.D., director of laparoscopic surgery at Norton Surgical Specialists, about surgical options for GERD.

  • Sunday December 26, 2021 12:30 pm ET on KET
  • Sunday December 26, 2021 11:30 am CT on KET
  • Sunday December 26, 2021 5:30 pm ET on KETKY
  • Sunday December 26, 2021 4:30 pm CT on KETKY
  • Monday December 27, 2021 2:00 pm ET on KET2
  • Monday December 27, 2021 1:00 pm CT on KET2
  • Friday December 31, 2021 1:30 pm ET on KETKY
  • Friday December 31, 2021 12:30 pm CT on KETKY
  • Friday December 31, 2021 6:00 pm ET on KET
  • Friday December 31, 2021 5:00 pm CT on KET
  • Sunday January 2, 2022 12:30 am ET on KETKY
  • Saturday January 1, 2022 11:30 pm CT on KETKY
  • Sunday January 2, 2022 7:00 am ET on KET2
  • Sunday January 2, 2022 6:00 am CT on KET2
  • Sunday January 2, 2022 9:00 am ET on KETKY
  • Sunday January 2, 2022 8:00 am CT on KETKY

ICU Care: The Care That You Hope That You Don't Need

  • Sunday January 2, 2022 12:30 pm ET on KET
  • Sunday January 2, 2022 11:30 am CT on KET
  • Sunday January 2, 2022 5:30 pm ET on KETKY
  • Sunday January 2, 2022 4:30 pm CT on KETKY
  • Monday January 3, 2022 2:00 pm ET on KET2
  • Monday January 3, 2022 1:00 pm CT on KET2
Jump to Upcoming Airdates

Recent

Medications: A Modern Miracle, But Are They Safe and Available

  • Sunday November 28, 2021 5:30 pm ET on KETKY
  • Sunday November 28, 2021 4:30 pm CT on KETKY

Oral Cancer and HPV: The Surprising Connection

  • Sunday November 28, 2021 9:00 am ET on KETKY
  • Sunday November 28, 2021 8:00 am CT on KETKY
  • Sunday November 28, 2021 12:30 am ET on KETKY
  • Saturday November 27, 2021 11:30 pm CT on KETKY
  • Friday November 26, 2021 11:30 pm ET on KET
  • Friday November 26, 2021 10:30 pm CT on KET
  • Friday November 26, 2021 6:00 pm ET on KET
  • Friday November 26, 2021 5:00 pm CT on KET
  • Friday November 26, 2021 1:30 pm ET on KETKY
  • Friday November 26, 2021 12:30 pm CT on KETKY
  • Monday November 22, 2021 2:00 pm ET on KET2
  • Monday November 22, 2021 1:00 pm CT on KET2
  • Sunday November 21, 2021 5:30 pm ET on KETKY
  • Sunday November 21, 2021 4:30 pm CT on KETKY
  • Sunday November 21, 2021 12:30 pm ET on KET
  • Sunday November 21, 2021 11:30 am CT on KET

Medical Information: Discerning the Wheat from the Chaff

  • Sunday November 21, 2021 9:00 am ET on KETKY
  • Sunday November 21, 2021 8:00 am CT on KETKY
  • Sunday November 21, 2021 12:30 am ET on KETKY
  • Saturday November 20, 2021 11:30 pm CT on KETKY
  • Friday November 19, 2021 11:30 pm ET on KET
  • Friday November 19, 2021 10:30 pm CT on KET
  • Friday November 19, 2021 6:00 pm ET on KET
  • Friday November 19, 2021 5:00 pm CT on KET
  • Friday November 19, 2021 1:30 pm ET on KETKY
  • Friday November 19, 2021 12:30 pm CT on KETKY
  • Monday November 15, 2021 2:00 pm ET on KET2
  • Monday November 15, 2021 1:00 pm CT on KET2
  • Sunday November 14, 2021 5:30 pm ET on KETKY
  • Sunday November 14, 2021 4:30 pm CT on KETKY
  • Sunday November 14, 2021 12:30 pm ET on KET
  • Sunday November 14, 2021 11:30 am CT on KET

Glaucoma and Cataracts: What's Clear and Are They Inevitable?

  • Sunday November 21, 2021 7:00 am ET on KET2
  • Sunday November 21, 2021 6:00 am CT on KET2
  • Tuesday November 16, 2021 12:30 pm ET on KETKY
  • Tuesday November 16, 2021 11:30 am CT on KETKY
  • Sunday November 14, 2021 9:00 am ET on KETKY
  • Sunday November 14, 2021 8:00 am CT on KETKY
  • Sunday November 14, 2021 12:30 am ET on KETKY
  • Saturday November 13, 2021 11:30 pm CT on KETKY
  • Friday November 12, 2021 11:30 pm ET on KET
  • Friday November 12, 2021 10:30 pm CT on KET
  • Friday November 12, 2021 6:00 pm ET on KET
  • Friday November 12, 2021 5:00 pm CT on KET
  • Friday November 12, 2021 1:30 pm ET on KETKY
  • Friday November 12, 2021 12:30 pm CT on KETKY
  • Monday November 8, 2021 2:00 pm ET on KET2
  • Monday November 8, 2021 1:00 pm CT on KET2
  • Sunday November 7, 2021 5:30 pm ET on KETKY
  • Sunday November 7, 2021 4:30 pm CT on KETKY
  • Sunday November 7, 2021 12:30 pm ET on KET
  • Sunday November 7, 2021 11:30 am CT on KET

Carotid Artery Disease: A Precursor to a Stroke

  • Sunday November 7, 2021 7:00 am ET on KET2
  • Sunday November 7, 2021 6:00 am CT on KET2

Environmental Pollution: Trees and Bushes as the Fix

  • Sunday November 14, 2021 7:00 am ET on KET2
  • Sunday November 14, 2021 6:00 am CT on KET2
  • Sunday November 7, 2021 9:00 am ET on KETKY
  • Sunday November 7, 2021 8:00 am CT on KETKY
  • Sunday November 7, 2021 12:30 am ET on KETKY
  • Saturday November 6, 2021 11:30 pm CT on KETKY
  • Friday November 5, 2021 11:30 pm ET on KET
  • Friday November 5, 2021 10:30 pm CT on KET
  • Friday November 5, 2021 6:00 pm ET on KET
  • Friday November 5, 2021 5:00 pm CT on KET
  • Friday November 5, 2021 1:30 pm ET on KETKY
  • Friday November 5, 2021 12:30 pm CT on KETKY
  • Monday November 1, 2021 2:00 pm ET on KET2
  • Monday November 1, 2021 1:00 pm CT on KET2
Top

Season 17 Episodes

Oral Cancer and HPV: The Surprising Connection

S17 E8 Length 27:53 Premiere Date 11.21.21

Medical Information: Discerning the Wheat from the Chaff

S17 E7 Length 28:01 Premiere Date 11.14.21

Glaucoma and Cataracts: Treating These Common Eye Diseases

S17 E6 Length 27:15 Premiere Date 11.7.21

Environmental Pollution: Trees and Bushes as the Fix

S17 E5 Length 27:46 Premiere Date 10.31.21

Carotid Artery Disease: A Precursor to a Stroke

S17 E4 Length 28:26 Premiere Date 10.24.21

GERD: Burning in the Chest and a Whole Lot More

S17 E3 Length 26:54 Premiere Date 10.17.21

Lung Cancer: Improving Treatment, Decreasing Mortality

S17 E2 Length 26:55 Premiere Date 10.10.21

Medications: Are They Safe and Effective?

S17 E1 Length 26:33 Premiere Date 10.3.21

Explore KET